| FICA | Federal Insurance Contributions Act |
|---|---|
| CAS | calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car... |
| CES-D | Center for Epidemiological Studies of Depression [scale] |
| CHAS | Center for Health Administration Studies |
| HCSD | Health Care Studies Division |
| A | Asian |
|---|---|
| SAO | South-East Asian ovalocytosis |
| CES-D | Center for Epidemiologic Studies - Depression |
| CES-D | Center for Epidemiologic Studies - Depression Scale |
| CES-D | Center for Epidemiological Studies Depression |
| asian americans | Persons living in the united states having origins in any of the original peoples of the far east, southeast asia, the pacific islands, or the indian subcontinent. (12 Dec 1998) |
|---|---|
| Asian influenza | A worldwide influenza, apparently originating in China in the summer of 1957, which produces a milder disease than that of the pandemic of 1917-1919. (05 Mar 2000) |
| rickettiosis, north asian tick-borne | One of the tick-borne rickettsial diseases of the eastern hemisphere, similar to rocky mountain spotted fever, but less severe, with fever, a small ulcer (eschar) at the site of the tick bite, swollen glands nearby (satellite lymphadenopathy), and a red raised (maculopapular) rash. (12 Dec 1998) |
| north asian tick-borne rickettsiosis | One of the tick-borne rickettsial diseases of the eastern hemisphere, similar to rocky mountain spotted fever, but less severe, with fever, a small ulcer (eschar) at the site of the tick bite, swollen glands nearby (satellite lymphadenopathy), and a red raised (maculopapular) rash. (12 Dec 1998) |
| tick-borne rickettsiosis, north asian | One of the tick-borne rickettsial diseases of the eastern hemisphere, similar to rocky mountain spotted fever, but less severe, with fever, a small ulcer (eschar) at the site of the tick bite, swollen glands nearby (satellite lymphadenopathy), and a red raised (maculopapular) rash. (12 Dec 1998) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
| sampling studies | Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled. (12 Dec 1998) |
| prospective studies | Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|